Stock Analysts

Honda’s (HMC) Fiscal Q3 Earnings Beat Estimates, Down Y/Y

Honda Motor Co., Ltd. ( HMC ) posted a 15.1% decrease in earnings to ¥136.5 billion ($1.13 billion) or ¥75.75 (63 cents) per share in the third quarter (ended Dec 31, 2014) of fiscal 2015 from ¥160.7 billion or ¥89.18 per share in the year-ago quarter. However, earnings per share surpassed the Zacks Consensus Estimate of 55 cents […]

Stock Analysts

Enterprise Q4 Earnings in Line, Revenues Lag Estimates

Enterprise Products Partners L.P. ( EPD ) reported fourth-quarter 2014 adjusted earnings per limited partner unit of 36 cents, which came in line with the Zacks Consensus Estimate but were lower than the year-ago quarterly earnings of 39 cents. For full-year 2014, adjusted earnings per limited partner unit were $1.47, which increased from $1.41 in the prior year but lagged the Zacks Consensus Estimate of $1.49 […]

Stock Analysts

Eastman Chemical Q4 Earnings a Dime Ahead, Profit Tanks

Eastman Chemical ( EMN ) topped earnings expectations in fourth-quarter 2014, but its profits slid in the quarter as a sizable loss on pension and postretirement benefit plans more than offset a rise in its sales. Eastman Chemical’s profit (as reported) tumbled around 95% to $16 million or 11 cents per share in the quarter from $346 million or $2.22 per share logged a year ago. Earnings, excluding pension/postretirement benefit plans loss and other one-time items, were $1.64 per share, topping the Zacks Consensus Estimate of $1.54 while surpassing the year-ago adjusted earnings of $1.35 per share […]

Stock Analysts

Simon Property (SPG) Posts In-Line Q4 FFO, Hikes Dividend

Simon Property Group, Inc. ( SPG ) a retail real estate investment trust (“REIT”), reported fourth-quarter 2014 comparable funds from operations (“FFO”) of $2.47 per share, which came in line with the Zacks Consensus Estimate. The bottom line comfortably beat the prior-year quarter figure of $2.20 per share. […]

Stock Analysts

Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015

Biotech company, Biogen Idec ( BIIB ), reported fourth quarter 2014 earnings per share of $4.08 (including the impact of stock-based compensation expense), way above the Zacks Consensus Estimate of $3.74 and the year-ago earnings of $2.33 per share. Biogen Idec Inc. – Quarterly EPS | FindTheBest Fourth quarter 2014 revenues increased 34% to $2.64 billion, just shy of the Zacks Consensus Estimate of $2.65 billion. […]

Mergers & Acquisitions

Continental Concludes Veyance Acquisition Following Approval by Brazilian Antitrust Authority

Continental Concludes Veyance Acquisition Following Approval by Brazilian Antitrust Authority – Antitrust authorities approve acquisition with certain conditions – Worldwide industrial business strengthened and global presence enhanced – ContiTech recorded sales of 5.4 billion euros in 2013 on pro forma basis PR Newswire HANOVER, Germany, and FAIRLAWN, Ohio, Jan. 30, 2015 HANOVER , Germany, and FAIRLAWN, Ohio , Jan. […]